auto_awesome
Want to know who else bid on this?
Proposal Forge correlates this contract with the original RFP, the losing bidders, and the next recompete window.
Department
National Research Council CanadaAmount
$2.1M
Province
ABType
Contribution
Agreement Number
172-2024-2025-Q4-1028947
Purpose
This proposal aims to develop a made-in-Canada solution to the threat posed by Highly Pathogenic Avian Influenza (HPAI) to Canadian livestock. Providence Therapeutics will initiate work to design and develop an mRNA vaccine drug candidate for a relevant strain using their mRNA and INTENT lipid nanoparticle (LNP) platforms.
Providence Therapeutics Holdings Inc. × National Research Council Canada
8 grants totalling $48.7M
Industrial Research Assistance Program
1,000 grants totalling $340.5M
Related Grants
| Recipient | Amount | Program |
|---|---|---|
| Miovision Technologies Incorporated (Amalco) | $7.9M | Industrial Research Assistance Program |
| GHGSat Incorporated | $7.2M | Industrial Research Assistance Program |
| Kinova inc | $6.3M | Industrial Research Assistance Program |
| e-Zinc Inc. | $6.1M | Industrial Research Assistance Program |
| Nanos Technology and Innovations Ltd | $5.0M | Industrial Research Assistance Program |